<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00628797</url>
  </required_header>
  <id_info>
    <org_study_id>07-200</org_study_id>
    <nct_id>NCT00628797</nct_id>
  </id_info>
  <brief_title>Effectiveness of UVA1-irradiation in the Treatment of Early Skin Fibrosis in Patients Suffering From Systemic Sclerosis</brief_title>
  <official_title>Multizenter-Studie Zur UVA-1 Therapie f√ºr Die Hautbeteiligung Bei Systemischer Sklerodermie</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nicolas Hunzelmann</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital Tuebingen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Cologne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Systemic scleroderma (SSc) is a rare chronic inflammatory diseae of the connective tissue
      involving the skin and internal organs. To date there is no proven therapy for the skin
      fibrosis available. A number of case reports and small uncontrolled cohort studies suggest
      that UVA1 therapy may improve skin fibrosis. The aim of this study is therefore to
      investigate whether treatment UVA1 in deed is effective in treating skin fibrosis in SSc
      using a randomized, intraindividual half body irradiation protocol.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    lack of recruitement
  </why_stopped>
  <start_date>February 2008</start_date>
  <completion_date type="Actual">November 2013</completion_date>
  <primary_completion_date type="Actual">July 2010</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>modified skin score</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>modified skin score</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>histologic examination</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">9</enrollment>
  <condition>Systemic Scleroderma</condition>
  <condition>Systemic Sclerosis</condition>
  <arm_group>
    <arm_group_label>A UVA1 B no UVA1</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>half body irradiation with random allocation right and left; after three months of treatment treatment of both sides</description>
  </arm_group>
  <arm_group>
    <arm_group_label>A UVA1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>UVA1</intervention_name>
    <description>intraindividual half body irradiation</description>
    <arm_group_label>A UVA1</arm_group_label>
    <other_name>ultraviolet light</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>UVA1</intervention_name>
    <description>60 J/cm2 at least 36 tx</description>
    <arm_group_label>A UVA1 B no UVA1</arm_group_label>
    <arm_group_label>A UVA1</arm_group_label>
    <other_name>Ultraviolet light</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  systemic sclerosis ACR criteria

          -  skin fibrosis at least involving the distal third of the lower arm

        Exclusion Criteria:

          -  photosensitizing drugs

          -  recent UV therapy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nicolas Hunzelmann</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Cologne, Dept. of Dermatology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Tuebingen, Dept. of Dermatology</name>
      <address>
        <city>Tuebingen</city>
        <state>BW</state>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Cologne, Dept. of Dermatology</name>
      <address>
        <city>Cologne</city>
        <state>NRW</state>
        <zip>50937</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 26, 2008</study_first_submitted>
  <study_first_submitted_qc>February 26, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 5, 2008</study_first_posted>
  <last_update_submitted>May 29, 2017</last_update_submitted>
  <last_update_submitted_qc>May 29, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Cologne</investigator_affiliation>
    <investigator_full_name>Nicolas Hunzelmann</investigator_full_name>
    <investigator_title>Prof. Dr. N. Hunzelmann</investigator_title>
  </responsible_party>
  <keyword>systemic sclerosis</keyword>
  <keyword>skin fibrosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sclerosis</mesh_term>
    <mesh_term>Scleroderma, Systemic</mesh_term>
    <mesh_term>Scleroderma, Diffuse</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

